(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 2.26% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.91%.
Baxter International's revenue in 2026 is $11,470,000,000.On average, 17 Wall Street analysts forecast BAX's revenue for 2026 to be $6,066,948,048,265, with the lowest BAX revenue forecast at $5,869,972,572,646, and the highest BAX revenue forecast at $6,321,827,075,772. On average, 17 Wall Street analysts forecast BAX's revenue for 2027 to be $6,195,163,056,017, with the lowest BAX revenue forecast at $5,975,439,756,442, and the highest BAX revenue forecast at $6,477,442,871,471.
In 2028, BAX is forecast to generate $6,346,642,883,724 in revenue, with the lowest revenue forecast at $6,090,729,864,219 and the highest revenue forecast at $6,644,949,575,147.